Skip to main content

The Center For Hyperhidrosis Reaches Milestone of 9,400 Successful Hyperhidrosis Surgeries

BEVERLY HILLS, CA - October 20, 2025 - PRESSADVANTAGE -

The Center For Hyperhidrosis has achieved a significant milestone in treating excessive sweating conditions, completing more than 9,400 successful surgical procedures with a documented 99.2 percent success rate. The Beverly Hills-based medical facility specializes in minimally invasive endoscopic surgeries that provide lasting relief for patients suffering from hyperhidrosis, a condition affecting millions worldwide.

The milestone reflects growing demand for permanent solutions to excessive sweating, particularly as awareness increases about available surgical options beyond traditional treatments. The center's co-founder, Dr. Eraj Basseri has pioneered advanced techniques in both Endoscopic Thoracic Sympathectomy (ETS) for hand sweating and Endoscopic Lumbar Sympathectomy (ELS) for foot sweating.

The Center For Hyperhidrosis logo

"Reaching this milestone represents thousands of patients who no longer have to plan their lives around excessive hand and foot sweating," said Dr. Eraj Basseri. "Each successful procedure validates the effectiveness of these minimally invasive techniques and reinforces why patients travel from across the globe to receive treatment here."

The Center For Hyperhidrosis surgical treatments have evolved significantly since the introduction of endoscopic approaches in the 1990s. These procedures, performed on an outpatient basis, typically allow patients to return to normal activities within days. The center's surgeons are among the very few in the United States and worldwide who perform both ETS and ELS procedures, offering comprehensive treatment options for various forms of hyperhidrosis.

Beyond surgical interventions, the facility serves as The Center For Hyperhidrosis educational resource about the condition, providing comprehensive information on symptoms, causes, and treatment alternatives. This educational component helps patients understand their options, from conservative approaches like topical treatments and medications to advanced surgical solutions.

The achievement comes at a time when hyperhidrosis awareness continues to grow. Studies indicate that approximately three percent of the global population experiences some form of excessive sweating, though many remain unaware that effective treatments exist. The condition, controlled by the sympathetic nervous system, can significantly impact quality of life, affecting professional interactions, personal relationships, and daily activities.

The Center's approach combines technological advancement with personalized patient care. Each treatment plan is tailored to individual needs, considering factors such as the severity and location of sweating, previous treatment attempts, and patient lifestyle. The facility also offers consultation services for facial sweating concerns.

Looking ahead, the medical team continues researching improvements in surgical techniques and exploring emerging treatment modalities. While genetic solutions remain theoretical, current mechanical interventions provide reliable, long-lasting results for most patients.

The Center for Hyperhidrosis operates from its Beverly Hills location, where it maintains state-of-the-art surgical facilities and consultation services. The medical team includes board-certified surgeons with specialized training in minimally invasive procedures and extensive experience in treating hyperhidrosis across all its manifestations.

###

For more information about The Center For Hyperhidrosis, contact the company here:

The Center For Hyperhidrosis - Beverly Hills
Sabrina Khalili
310 557 3037
sabrina@centerforhyperhidrosis.com
9033 Wilshire Blvd #200, Beverly Hills, CA 90211, United States

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.09
+6.61 (3.05%)
AAPL  263.21
+0.97 (0.37%)
AMD  240.04
-0.52 (-0.22%)
BAC  51.86
-0.18 (-0.36%)
GOOG  250.39
-6.63 (-2.58%)
META  734.55
+2.38 (0.33%)
MSFT  515.50
-1.29 (-0.25%)
NVDA  182.10
-0.54 (-0.30%)
ORCL  278.65
+1.47 (0.53%)
TSLA  448.43
+1.00 (0.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.